Min Liao

Title: Min Liao: Innovator in Viral Research

Introduction

Min Liao is a prominent inventor based in Hangzhou, China. He has made significant contributions to the field of viral research, particularly in the development of vaccines and monoclonal antibodies. With a total of 2 patents, Liao's work is crucial for advancing medical science and improving animal health.

Latest Patents

Liao's latest patents include the "Hybridoma Cell Line for Secreting Anti-Rabies Virus M Protein Monoclonal Antibody and Application Thereof." This invention focuses on creating a hybridoma cell line that can produce a specific monoclonal antibody against the rabies virus. Another notable patent is related to a "Type II Pseudorabies Virus Attenuated Strain, Its Preparation Method and Application." This invention discloses a gE/TK-double-deficient strain of the pseudorabies virus, named PRV-HD/c strain, which has reduced pathogenicity and strong immunogenicity. The strain is derived from a newly isolated strain of pseudorabies virus type II and is designed to provide effective immunity to susceptible animals such as pigs and mice.

Career Highlights

Min Liao is affiliated with Zhejiang University, where he conducts his research and development activities. His work at the university has positioned him as a key figure in the field of virology and vaccine development.

Collaborations

Liao collaborates with notable colleagues, including Jiyong Zhou and Jinyan Gu, who contribute to his research efforts and enhance the impact of his inventions.

Conclusion

Min Liao's innovative work in viral research and vaccine development demonstrates his commitment to improving animal health and advancing scientific knowledge. His patents reflect significant advancements in the field, showcasing his role as a leading inventor in virology.